New 9-Day combo shows promise for rare bone marrow disease

This study tested a new 9-day treatment plan for people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. The treatment combines three drugs (rabbit antithymocyte globulin, cyclosporine, and levamisole) to suppress the immune system and help the bone marrow recover. The goal was to see if this approach could improve blood counts and reduce side effects compared to standard therapy. Forty newly diagnosed patients took part in this phase 2 trial.